PolyPid Stock (NASDAQ:PYPD)
Previous Close
$5.33
52W Range
$3.06 - $5.73
50D Avg
$4.87
200D Avg
$4.52
Market Cap
$99.23M
Avg Vol (3M)
$215.81K
Beta
1.42
Div Yield
-
PYPD Company Profile
PolyPid Ltd. is an advanced-stage biopharmaceutical company specializing in the development, manufacturing, and commercialization of therapeutic solutions. These solutions are based on its proprietary polymer-lipid encapsulation matrix (PLEX) platform, with the goal of addressing significant unmet medical needs. The company's leading product candidate, D-PLEX100, is currently undergoing Phase III clinical trials. It is being evaluated for its efficacy in preventing surgical site infections (SSIs) following both sternal (bone) and abdominal (soft tissue) procedures. Established in 2008, PolyPid Ltd. is headquartered in Petah Tikva, Israel.